Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 19, 2025 18:00 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
December 15, 2025 16:05 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong
November 20, 2025 08:30 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling
November 14, 2025 08:30 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth
November 13, 2025 08:30 ET | Source: AEON Biopharma Inc

AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data

AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data
November 13, 2025 08:30 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes
October 01, 2025 08:00 ET | Source: AEON Biopharma Inc

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19
November 29, 2022 04:36 ET | Source: Allied Market Research

Global Botulinum Toxin Market Is Expected to Reach $13.1 Billion by 2031: Says AMR

Portland, OR, Nov. 29, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Botulinum Toxin Market was estimated at $5.8 billion in 2021 and is expected...
June 26, 2022 23:12 ET | Source: Checkmate Capital

Checkmate Capital Group and KAIST Venture Investment Holdings Announce Partnership & Selection as TIPS Operator

LOS ANGELES and SEOUL, South Korea, June 26, 2022 (GLOBE NEWSWIRE) -- A consortium formed by KAIST Venture Investment Holdings and Checkmate Capital Group has been selected as a program operator for...